[{"Assets_0_Q2_USD":257445000.0,"CommonStockSharesConverted_0_Q2_shares":31297423.0,"CommonStockSharesOutstanding_0_Q2_shares":31297423.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":-27139000.0,"NetIncomeLossConverted_1_Q2_USD":-17142000.0,"NetIncomeLossConverted_2_Q2_USD":-30689000.0,"StockholdersEquity_0_Q2_USD":247915000.0,"EarningsPerShareBasic_1_Q2_USD":-0.7,"EarningsPerShareBasic_2_Q2_USD":-2.19,"Ticker":"TPTX","CIK":"1595893","name":"TURNING POINT THERAPEUTICS, INC.","OfficialName":"Turning Point Therapeutics Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1579986704.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190806"}]